In contrast, patients with COVID-19 had significantly lower SEMA3A concentrations (14 ng/mL, IQR 11–16 vs. 21 ng/mL, IQR 15–24, p ≤ 0.0001). The gene discussed is SEMA3A; the disease is COVID-19.